Bio Marketing

Hugel's 'Letybo' First in Korea to Obtain Marketing Approval from Australia

Obtained marketing approval on the 23rd (local time) from the Therapeutic Goods Administration (TGA) of Australia for the indication of gl...

 November 25, 2022 | News

AcuCort signs its first commercial agreement for the company's drug Zeqmelit™

Kamada Ltd., a leading global biopharmaceutical company, has a well-established infrastructure for marketing, sales, and distribution of commercial pharmac...

 November 24, 2022 | News

GenScript takes home Executive of the Year - Biotechnology at the SBR Management Excellence Awards 2022

Global biotechnology corporation, GenScript Asia Pacific's President, Mr. Johnson Wang bagged the Executive of the Year - Biotechnology title at ...

 November 21, 2022 | News

MEDICOX Signs Contract with ORAMED to Distribute Oral Insulin in South Korea

  MEDICOX secures distribution right for ORAMED's oral insulin in South Korea after phase 3 of FDA approval- Contract scale up to 18...

 November 21, 2022 | News

Simcere and Idorsia enter into a licensing agreement for daridorexant in China

Jinsheng Ren,Chairman and CEO of Simcere commented: "This licensing agreement represents an important and exciting step in pursuing Simcere's mission of p...

 November 16, 2022 | News

Twitter dissent hits Big Pharma.

After many days of unpredictability on Twitter, people easily dropped the stock of the pharmaceutical corporation Eli Lilly with a single message, demonstr...

 November 15, 2022 | News

Malvern Panalytical and Applied Photophysics announce distribution agreement for Protein Stable’s SUPR-DSF

Malvern Panalytical (Malvern, UK) and Applied Photophysics (Leatherhead, UK) have today announced their commercial agreement for Malvern Panalytical to dis...

 November 14, 2022 | News

Singapore to host the 7th World One Health Congress

The 7th World One Health Congress (WOHC), the world's premier event to advance the One Health agenda, will take place in Singapore at the iconic ...

 October 26, 2022 | News

Menarini Silicon Biosystems's CELLSEARCH® CMMC and HER2-CTC Liquid Biopsy Tests obtain Reimbursement Codes with Preliminary Pricing Determination

Menarini Silicon Biosystems (MSB), Inc. is announcing that the AMA has issued Current Procedural Terminology (CPT®) Proprietary Laboratory Analyse...

 October 14, 2022 | News

General Automation Lab Technologies is now Isolation Bio

Isolation Bio, Inc., previously operating as General Automation Lab Technologies (GALT), Inc., has announced its rebranding effort to better reflect the co...

 October 04, 2022 | News

ProBioGen Receives Employer of the Future and Top Service Awards

The Berlin-based biopharmaceutical company ProBioGen received the Employer of the Future and the Top Service awards at the DIGITAL X 2022 event i...

 September 14, 2022 | News

Biosynth Carbosynth, vivitide and Pepscan Rebrand to Biosynth

Biosynth Carbosynth, vivitide and Pepscan are pleased to announce today their rebranding to Biosynth to match their parent group and the launch of their si...

 September 08, 2022 | News

Menarini Group's Elacestrant Marketing Authorization Application Accepted for Review by the European Medicines Agency (EMA)

lacestrant, if approved, would be the first oral selective estrogen receptor degrader (SERD) to be available for patients suffering from second-line...

 August 21, 2022 | News

New Corporate Identity for VACUUBRAND GMBH + CO KG

As of today, you can experience our new corporate identity – the culmination of feedback from our customers, partners and employees. The focus is on ...

 July 07, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in